ALEXANDRIA, Va., June 5 -- United States Patent no. 12,275,766, issued on April 15, was assigned to Janssen Biotech Inc. (Horsham, Pa.).
"Neoantigen peptide mimics" was invented by Vinod Krishna (Philadelphia), Manuel Alejandro Sepulveda (West Windsor, N.J.), Vipul Bhargava (Warrington, Pa.), Iqbal S. Grewal (Newtown, Pa.) and Kurtis Bachman (Wayne, Pa.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are polypeptide fragments and polynucleotides based on mutant capicua transcriptional repressor (CIC), catenin beta 1 (CTNNB1), v-erb-b2 erythroblastic leukemia viral oncogene homolog B (ERBB2), kirsten rat sarcoma (KRAS), phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PI...